Molecular Templates is a clinical-stage biopharmaceutical company focused on the discovery and development of biologic therapeutics for cancer. Co. utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies (ETBs). ETBs use a genetically engineered version of the Shiga-like Toxin A subunit (SLTA), a ribosome inactivating bacterial protein. In its wild-type form, SLT is thought to induce its own entry into a cell when proximal to the cell surface membrane, self-route to the cytosol, and enzymatically and irreversibly shut down protein synthesis via ribosome inactivation. Co. has developed ETBs to various targets, including PD-L1, CD38, and CTLA-4. We show 27 historical shares outstanding datapoints in our MTEM shares outstanding history coverage, used to compute MTEM market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing MTEM market cap history over the course of time is important for investors
interested in comparing MTEM's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of MTEM versus a peer is one thing; comparing
MTEM market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like MTEM can fluctuate over the course of history.
With this page we aim to empower investors researching MTEM by allowing them to research the MTEM market cap history. |
Free MTEM Email Alerts:
Video: The Importance of Market Cap
